Combined with these results, we hypothesized that the molecular mechanism of Astragaloside IV against PF is via regulating PGC‐1α, promoting mitochondrial biosynthesis, regulating excess ROS and blocking peritoneal mesothelial cell apoptosis, thereby preventing and treating PF. The gene discussed is PPARGC1A; the disease is pemphigus foliaceus.